The trial that could transform care for people with blood disorders such as sickle cell and rare blood types.
In what can be called a breakthrough in medical science, red blood cells grown in a laboratory have been transfused into volunteers in a world-first clinical trial.
The manufactured blood cells — grown from donor stem cells — could revolutionize treatments for people with blood disorders such as sickle cell disease if proven to be safe and effective.
Comments are closed.